冠脉CTA在非ST段抬高型急性冠脉综合征患者中的预后价值
基于VERDICT试验中978例非ST段抬高型急性冠脉综合征(NSTEACS)患者,在侵入性冠脉造影(ICA)前进行盲法冠脉CTA评估冠脉病变严重程度与范围。中位随访4.2年,主要终点发生208例(21.3%),冠脉CTA与ICA对长期风险的评估等效。
要点
- 冠脉CTA定义的阻塞性CAD与主要终点升高相关(HR 1.74)。
- 冠脉CTA定义的高危CAD与主要终点升高相关(HR 1.56)。
- 冠脉CTA在NSTEACS长期风险评估方面与ICA等效。
核心结论
- 冠脉CTA在评估NSTEACS患者长期风险方面与侵入性冠脉造影等效。
研究设计与样本
- VERDICT试验在NSTEACS患者中于ICA前进行临床盲法冠脉CTA,共978例患者接受冠脉CTA与ICA检查。
- CAD严重程度定义为阻塞性(冠脉狭窄≥50%)或非阻塞性。
- CAD范围定义为高危(阻塞性左主干或前降支近段狭窄和/或多支病变)或非高危。
- 主要终点为全因死亡、非致死性再发心肌梗死、因难治性心肌缺血住院或心力衰竭的复合终点。
主要发现
- 中位随访4.2年(四分位距2.7至5.5年)期间,208例(21.3%)发生主要终点。
- 冠脉CTA定义的阻塞性CAD患者主要终点发生率较非阻塞性CAD高至1.7倍(HR 1.74;95%CI 1.22至2.49;p=0.002)。
- ICA定义的阻塞性CAD患者主要终点发生率较非阻塞性CAD升高(HR 1.54;95%CI 1.13至2.11;p=0.007)。
- 冠脉CTA定义的高危CAD患者主要终点发生率较非高危CAD高1.5倍(HR 1.56;95%CI 1.18至2.07;p=0.002)。
- ICA定义的高危CAD呈现相似趋势(HR 1.28;95%CI 0.98至1.69;p=0.07)。
关键数值与推荐
- 阻塞性CAD定义为冠脉狭窄≥50%。
- 高危CAD定义为阻塞性左主干或前降支近段狭窄和/或多支病变。
- 主要终点为全因死亡、非致死性再发心肌梗死、因难治性心肌缺血住院或心力衰竭的复合终点。
临床怎么用
- 对NSTEACS患者,冠脉CTA可用于长期风险分层,识别阻塞性与高危CAD患者以指导后续管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severity and extent of coronary artery disease (CAD) assessed by invasive coronary angiography (ICA) guide treatment and may predict clinical outcome in patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). OBJECTIVES: This study tested the hypothesis that coronary computed tomography angiography (CTA) is equivalent to ICA for risk assessment in patients with NSTEACS. METHODS: The VERDICT (Very Early Versus Deferred Invasive Evaluation Using Computerized Tomography in Patients With Acute Coronary Syndromes) trial evaluated timing of treatment in relation to outcome in patients with NSTEACS and included a clinically blinded coronary CTA conducted prior to ICA. Severity of CAD was defined as obstructive (coronary stenosis ≥50%) or nonobstructive. Extent of CAD was defined as high risk (obstructive left main or proximal left anterior descending artery stenosis and/or multivessel disease) or non-high risk. The primary endpoint was a composite of all-cause death, nonfatal recurrent myocardial infarction, hospital admission for refractory myocardial ischemia, or heart failure. RESULTS: Coronary CTA and ICA were conducted in 978 patients. During a median follow-up time of 4.2 years (interquartile range: 2.7 to 5.5 years), the primary endpoint occurred in 208 patients (21.3%). The rate of the primary endpoint was up to 1.7-fold higher in patients with obstructive CAD compared with in patients with nonobstructive CAD as defined by coronary CTA (hazard ratio [HR]: 1.74; 95% confidence interval [CI]: 1.22 to 2.49; p = 0.002) or ICA (HR: 1.54; 95% CI: 1.13 to 2.11; p = 0.007). In patients with high-risk CAD, the rate of the primary endpoint was 1.5-fold higher compared with the rate in those with non-high-risk CAD as defined by coronary CTA (HR: 1.56; 95% CI: 1.18 to 2.07; p = 0.002). A similar trend was noted for ICA (HR: 1.28; 95% CI: 0.98 to 1.69; p = 0.07). CONCLUSIONS: Coronary CTA is equivalent to ICA for the assessment of long-term risk in patients with NSTEACS. (Very Early Versus Deferred Invasive Evaluation Using Computerized Tomography in Patients With Acute Coronary Syndromes [VERDICT]; NCT02061891).
引用
- Kofoed KF, Engstrøm T, Sigvardsen PE, et al. Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. J Am Coll Cardiol. 2021. PMID: 33632478. doi:10.1016/j.jacc.2020.12.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。